Leroux M, Jacobs H K, Rabkin S W, Desjardins P R
Clin Chim Acta. 1977 Oct 15;80(2):253-64. doi: 10.1016/0009-8981(77)90032-8.
A DEAE-cellulose mini-column method has been developed which allows for the quantitation in human serum of creatine kinase Z, a sub-band of creatine kinase first described by Lim ((1975) Clin. Chem. 21, 975, Abstract 181) and Sax et al. (Sax, S.M., Moore, J.J., Giegel, J.L. and Welsh, M. (1976) Clin. Chem. 22, 87). We have shown that creatine kinase Z is rather unstable in nature, and converts to a form which electrophoreses with creatine kinase MM on agarose gel electrophoresis. CK-Z is not present in normal human serum. CK-Z is present in human heart extracts, in patients with myocardial infarcts and in patients with skeletal muscle trauma. In infarct patients CK-Z levels paralleled changes in the CK-MB levels. CK-Z ranged in activity from 8.8-67.2 I.U. whereas CK-MB ranged from 29.6-121.6 I.U. in infarct patients. CK-Z and CK-MB activity were measured at or close to the peak rise in total CK activity.
已开发出一种二乙氨基乙基纤维素微型柱方法,可用于定量检测人血清中的肌酸激酶Z,这是肌酸激酶的一个亚带,最初由林((1975年)《临床化学》21卷,975页,摘要181)以及萨克斯等人(萨克斯,S.M.,摩尔,J.J.,吉格尔,J.L.和威尔士,M.(1976年)《临床化学》22卷,87页)描述。我们已表明,肌酸激酶Z在本质上相当不稳定,会转化为一种在琼脂糖凝胶电泳中与肌酸激酶MM一起电泳的形式。正常人血清中不存在CK-Z。CK-Z存在于人心肌提取物、心肌梗死患者和骨骼肌创伤患者中。在梗死患者中,CK-Z水平与CK-MB水平的变化平行。在梗死患者中,CK-Z的活性范围为8.8 - 67.2国际单位,而CK-MB的活性范围为29.6 - 121.6国际单位。CK-Z和CK-MB活性是在总CK活性达到峰值上升时或接近峰值上升时进行测量的。